Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,620 shares at $83.23 ($384K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Seasonal sale ($384k) by Chief Research Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.02 | 1,375 | $114K | 29.8% |
| 2 | $83.02 | 1,375 | $114K | 29.8% |
| 3 | $83.23 | 671 | $56K | 14.6% |
| 4 | $83.23 | 671 | $56K | 14.6% |
| 5 | $82.48 | 528 | $44K | 11.4% |
| Total | $83.02 avg | 4,620 |
| $384K |
| 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |